About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Medical Oncology Updates in NETs
By
2023 Johns Hopkins Updates in Gastrointestinal Cancers
FEATURING
Pamela Kunz
By
2023 Johns Hopkins Updates in Gastrointestinal Cancers
FEATURING
Pamela Kunz
387 views
March 7, 2023
For more accreditation information, please visit
https://integrityce.com/HopkinsGI2023
1 Comment
Login to view comments.
Click here to Login
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Related Content
AUTOPLAY
ON
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
24:56
Florida Gastroenterologic Society
Neuroendocrine Tumors in the GI Tract
Feat.
A. Luthra
06:03
Total Health
2024 Updates on Targeted Approaches for GI Cancers and New Data in N…
Feat.
A. Grothey
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
13:06
Yale Cancer Center
NETs 101 and Overview of Medical Management
Feat.
P. Kunz
15:20
Integrity Continuing Education
Sequencing Systemic Treatments for Well-Differentiated NETs
Feat.
J. Strosberg
16:31
Integrity Continuing Education
Debates in NET Treatment: Surgery vs. IR for Liver-Limited Disease
Feat.
E. Liu
13:47
Oncology Data Advisor
New Developments in Neuroendocrine Tumor Treatment
Feat.
S. Kareff,
A. Chauhan
22:31
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Controversies in Management of Neuroendocrine Tumors
Feat.
T. Pawlik
19:29
Integrity Continuing Education
Metastatic Grade 2 NET: Case Presentation and Panel Discussion
Feat.
A. De Jesus-Acosta,
L. Bjork Solnes,
J. Strosberg,
E. Liu,
R. Lidell
11:41
Northwell Health
Neuroendocrine Cancers of the Lung
Feat.
N. Seetharamu
12:23
Integrity Continuing Education
2L Therapy for Metastatic NET: Case Presentation and Panel Discussion
Feat.
A. De Jesus-Acosta,
L. Bjork Solnes,
J. Strosberg,
E. Liu,
R. Lidell
51:13
Yale Cancer Center
The Second Century in the Land of Neuroendocrine Tumors
Feat.
J. Yao
02:49
ecancer
ESMO 2023 Insights: "Alliance A021602 Study - Cabozantinib vs. …
Feat.
J. Chan
37:15
Total Health
Practical Considerations in the Management of Advanced Neuroendocrin…
Feat.
J. Del Rivero
09:59
Insights from 2024 ESMO Sarcoma and Rare Cancers Congress
Lurbinectedin + Irinotecan in Pre-Treated Gastroenteropancreatic Neu…
Feat.
R. Garcia-Carbonero
07:11
Total Health
ASCO 2022 Non-Colorectal Cancer Updates
Feat.
D. Catenacci
10:22
Yale Cancer Center
Imaging Neuroendocrine Tumors
Feat.
D. Pucar
05:36
Moffitt Cancer Center
Expert Commentary: Hemicolectomy vs. Appendectomy for Patients With …
Feat.
J. Strosberg
27:42
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Updates on Gastroenteropancreatic Neur…
Feat.
D. Bing Zhen
